4//SEC Filing
Ferguson James J. III 4
Accession 0001493152-22-036232
CIK 0001582554other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:17 AM ET
Size
5.6 KB
Accession
0001493152-22-036232
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock Option (right to Buy)
2022-12-20+625,000→ 625,000 totalExercise: $0.53Exp: 2032-12-20→ Common Stock (625,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001769041
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 11:17 AM ET
- Size
- 5.6 KB